Pharmaceutical Technology

JULY 26, 2022

NewAmsterdam Pharma has signed a definitive business combination agreement with special purpose acquisition company (SPAC) Frazier Lifesciences Acquisition (FLAC). The deal will make NewAmsterdam Pharma a publicly listed company focusing on oral treatments for cardiometabolic diseases.

Pharma 59

Pharma Specialization Healthcare Healthcare 59

pharmaphorum

OCTOBER 14, 2022

A consortium of industry and academic groups – led by Johnson & Johnson’s pharma division Janssen – has been set up to tackle the environmental impact of digital health products, specifically aimed at minimising waste that could end up in landfill. The project started on 1 October and is scheduled to complete in September 2026.

Leads 125

Leads Electronics Ethics Healthcare 125

PM360

SEPTEMBER 21, 2023

Under the pathway, manufacturers can use safety and efficacy data from existing products in their applications for their own products. The product, manufactured by ARS Pharma and Neurelis Pharma, would be the first needle-free epinephrine alternative to autoinjectors, such as the EpiPen.

Management 105

Management Manufacturing Sales Competition 105

pharmaphorum

JANUARY 18, 2023

NewAmsterdam Pharma’s bold play to resurrect an all-but defunct cholesterol-lowering drug class has been rewarded with a positive phase 2 trial of its oral CETP inhibitor obicetrapib. Amgen licensed the rights to NewAmsterdam in 2020.

Pharma 59

Pharma Prospecting Patients Safety 59

Pharma Marketing Network

MAY 12, 2021

Billion by 2026 with a CAGR of 37.2% Physicians and patients raise legitimate questions and concerns about the safety, effectiveness, and accessibility of telehealth. The post A Look Into Telehealth in 2021 and Beyond appeared first on Pharma Marketing Network. Billion in 2019 and Expected to Reach USD 171.81

Physicians 59

Physicians Patients Safety Marketing 59

European Pharmaceutical Review

AUGUST 22, 2024

1 within the next seven years, the GLP-1R market will “expand to 35 approved products from 16 companies” Jasper Morley, Pharma Analyst at GlobalData noted that these products include Novo Nordisk’s Ozempic and Wegovy and Eli Lilly’s Trulicity and Mounjaro ®. The treatment was also shown to hold a “good safety and tolerability” profile.

Medicine 59

Medicine Marketing Manufacturing Sales 59

Pharmaceutical Technology

JANUARY 31, 2023

FDA director Robert Califf gave his prognosis for the pharma industry at this year’s JP Morgan Healthcare Conference in San Francisco over January 9–12. That leaves three years for pharma companies to prepare.

FDA 52

FDA Prescription Medicine Biopharma 52